Exact Mass: 362.1623826
Exact Mass Matches: 362.1623826
Found 268 metabolites which its exact mass value is equals to given mass value 362.1623826,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Thyrotropin releasing hormone
Thyrotropin-releasing hormone (TRH), also called thyrotropin-releasing factor (TRF), thyroliberin or protirelin, is a tripeptide hormone that stimulates the release of thyroid-stimulating hormone and prolactin by the anterior pituitary. In humans, it also acts as a prolactin-releasing factor. It is also a neurotransmitter in the central nervous system. TRH is produced by the hypothalamus and travels across the median eminence to the pituitary via the hypophyseal portal system. In addition to the brain, TRH can also be detected in other areas of the body including the gastrointestinal system and pancreatic islets. Medical preparations of TRH are used in diagnostic tests of thyroid disorders and in acromegaly. [HMDB] This compound belongs to the family of N-acyl-alpha Amino Acids and Derivatives. These are compounds containing an alpha amino acid which bears an acyl group at his terminal nitrogen atom. C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C76367 - Thyrotropin-Releasing Hormone Analogue V - Various > V04 - Diagnostic agents > V04C - Other diagnostic agents > V04CJ - Tests for thyreoidea function D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones KEIO_ID G117; [MS2] KO008963 KEIO_ID G117 Protirelin is a highly conserved neuropeptide that exerts the hormonal control of thyroid-stimulating hormone (TSH) levels as well as neuromodulatory functions.
DU 122290
C19H26N2O3S (362.1664046000001)
2-Ethylhexyl diphenyl phosphate
C20H27O4P (362.16468720000006)
Chlormadinone
(2S)-2-(4,6-Dimethylpyrimidin-2-yl)oxy-3,3-diphenylbutanoic acid
C22H22N2O3 (362.16303419999997)
(E)-N-(2-Amino-4-fluorophenyl)-3-(1-cinnamyl-1H-pyrazol-4-yl)acrylamide
Thyrotropin-releasing factor
[3R-(3alpha,3aalpha,4beta,5alpha,6aalpha)]-4-[(beta-D-Gulucopyranosyloxy)methyl]hexsahydro-3-(hydroxymethyl)-5-methyl-2H-cyclopenta[b]furan-2-one
[3R-(3alpha,3aalpha,4beta,5alpha,6aalpha)]-3-[(beta-D-Gulucopyranosyloxy)methyl]hexsahydro-4-(hydroxymethyl)-5-methyl-2H-cyclopenta[b]furan-2-one
glucosyl 5,8-dihydroxy-2,6-dimethyl-(2E,6E)-octadienoate
(+)-chloropuupehenone|21-Chloropuupehenone|chloropuupehenone|chlorpuupehenone
(+)-chloropuupehenol|(4aS,6aR,12bS)-2H-11-chloro-1,3,4,4a,5,6,6a,12b-octahydro-4,4,6a,12b-tetramethyl-benzo[a]xanthene-9,10-diol|21-Chloropuupehenol
stryvomitine
C22H22N2O3 (362.16303419999997)
A monoterpenoid indole alkaloid with formula C22H22N2O3, isolated from the seeds of Strychnos nux-vomica.
6-hydroxy-4,7-dimethyl-3-oxooctahydrocyclopenta[c]pyran-7-yl hexopyranoside
Thyrotropin releasing hormone
Protirelin is a highly conserved neuropeptide that exerts the hormonal control of thyroid-stimulating hormone (TSH) levels as well as neuromodulatory functions.
Protirelin
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C76367 - Thyrotropin-Releasing Hormone Analogue V - Various > V04 - Diagnostic agents > V04C - Other diagnostic agents > V04CJ - Tests for thyreoidea function A tripeptide composed of L-pyroglutamyl, L-histidyl and L-prolinamide residues joined in sequence. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones Protirelin is a highly conserved neuropeptide that exerts the hormonal control of thyroid-stimulating hormone (TSH) levels as well as neuromodulatory functions.
2-Ethylhexyldiphenyl phosphate
C20H27O4P (362.16468720000006)
CONFIDENCE standard compound; INTERNAL_ID 1223; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10480; ORIGINAL_PRECURSOR_SCAN_NO 10478 CONFIDENCE standard compound; INTERNAL_ID 1223; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10498; ORIGINAL_PRECURSOR_SCAN_NO 10497 CONFIDENCE standard compound; INTERNAL_ID 1223; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10504; ORIGINAL_PRECURSOR_SCAN_NO 10502 CONFIDENCE standard compound; INTERNAL_ID 1223; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10529; ORIGINAL_PRECURSOR_SCAN_NO 10526 CONFIDENCE standard compound; INTERNAL_ID 1223; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10527; ORIGINAL_PRECURSOR_SCAN_NO 10522 CONFIDENCE standard compound; INTERNAL_ID 1223; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10532; ORIGINAL_PRECURSOR_SCAN_NO 10528
Ala Ala Ala Met
Ala Ala Cys Val
Ala Ala Met Ala
Ala Ala Val Cys
Ala Cys Ala Val
Ala Cys Gly Ile
Ala Cys Gly Leu
Ala Cys Ile Gly
Ala Cys Leu Gly
Ala Cys Val Ala
Ala Gly Cys Ile
Ala Gly Cys Leu
Ala Gly Ile Cys
Ala Gly Leu Cys
Ala Ile Cys Gly
Ala Ile Gly Cys
Ala Leu Cys Gly
Ala Leu Gly Cys
Ala Met Ala Ala
Ala Val Ala Cys
Ala Val Cys Ala
Cys Ala Ala Val
Cys Ala Gly Ile
Cys Ala Gly Leu
Cys Ala Ile Gly
Cys Ala Leu Gly
Cys Ala Val Ala
Cys Gly Ala Ile
Cys Gly Ala Leu
Cys Gly Ile Ala
Cys Gly Leu Ala
Cys Ile Ala Gly
Cys Ile Gly Ala
Cys Leu Ala Gly
Cys Leu Gly Ala
Cys Val Ala Ala
Gly Ala Cys Ile
Gly Ala Cys Leu
Gly Ala Ile Cys
Gly Ala Leu Cys
Gly Cys Ala Ile
Gly Cys Ala Leu
Gly Cys Ile Ala
Gly Cys Leu Ala
Gly Gly Met Val
Gly Gly Val Met
Gly Ile Ala Cys
Gly Ile Cys Ala
Gly Leu Ala Cys
Gly Leu Cys Ala
Gly Met Gly Val
Gly Met Val Gly
Gly Val Gly Met
Gly Val Met Gly
Ile Ala Cys Gly
Ile Ala Gly Cys
Ile Cys Ala Gly
Ile Cys Gly Ala
Ile Gly Ala Cys
Ile Gly Cys Ala
Leu Ala Cys Gly
Leu Ala Gly Cys
Leu Cys Ala Gly
Leu Cys Gly Ala
Leu Gly Ala Cys
Leu Gly Cys Ala
Met Ala Ala Ala
Met Gly Gly Val
Met Gly Val Gly
Met Val Gly Gly
Val Ala Ala Cys
Val Ala Cys Ala
Val Cys Ala Ala
Val Gly Gly Met
Val Gly Met Gly
Val Met Gly Gly
3-hydroxy-2-(3-methyl-2-(((3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)cyclopent-2-en-1-yl)propanoic acid
2-METHYL-1-(4-MORPHOLINOPHENYL)-5-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID
C22H22N2O3 (362.16303419999997)
4-{[Dimethyl(2-methyl-2-propanyl)silyl]oxy}-5,8-dimethoxy-2-napht hoic acid
C19H26O5Si (362.15494259999997)
tert-butyl 4-[(1,3-dioxoisoindol-2-yl)methyl]-4-fluoropiperidine-1-carboxylate
chlormadinon
G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03D - Progestogens > G03DB - Pregnadien derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000726 - Androgen Antagonists C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents
Tributyl[(Z)-2-ethoxyvinyl]stannane
C16H34OSn (362.16315039999995)
4-(4-((TERT-BUTOXYCARBONYL)AMINO)-1-METHYL-1H-PYRROLE-2-CARBOXAMIDO)-1-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID
Protirelina
H - Systemic hormonal preparations, excl. sex hormones and insulins > H01 - Pituitary and hypothalamic hormones and analogues > H01A - Anterior pituitary lobe hormones and analogues > H01AB - Thyrotropin
5-(3-Carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid
C22H22N2O3 (362.16303419999997)
2-(1-ethylpyrrolidin-2-yl)-5-(5-ethylsulfonyl-2-methoxyphenyl)-1H-pyrrole
C19H26N2O3S (362.1664046000001)
(2S)-2-(4,6-Dimethylpyrimidin-2-yl)oxy-3,3-diphenylbutanoic acid
C22H22N2O3 (362.16303419999997)
6-(4-Methylphenyl)-2,3-diphenylimidazo[1,2-b][1,2,4]triazine
1-(4-methoxyphenyl)-3-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)pyrrolidine-2,5-dione
C22H22N2O3 (362.16303419999997)
4-[(2,6-Dimorpholino-3-pyridinyl)amino]-4-oxo-2-butenoic acid
(3R)-3-{[(3R)-3-{[(3R)-3-{[(3R)-3-hydroxybutanoyl]oxy}butanoyl]oxy}butanoyl]oxy}butanoic acid
A (3R)-3-hydroxybutanoic acid oligomer resulting from the formal intermolecular condensation of the hydroxy and carboxy groups of (3R)-3-hydroxybutanoic acid to give a chain in which four units of the monomer are linked together by three ester bonds.
3-[Oxo-[4-(2-phenylethyl)-1-piperazinyl]methyl]-1-benzopyran-2-one
C22H22N2O3 (362.16303419999997)
[2-(4-Methoxyphenyl)-6-methyl-4-quinolinyl]-(4-morpholinyl)methanone
C22H22N2O3 (362.16303419999997)
N-[4-[[(4-tert-butylphenyl)-oxomethyl]amino]phenyl]-2-furancarboxamide
C22H22N2O3 (362.16303419999997)
2-[2-(2,5-Dimethyl-1-phenyl-3-pyrrolyl)-2-oxoethyl]-3a,4,7,7a-tetrahydroisoindole-1,3-dione
C22H22N2O3 (362.16303419999997)
(4S,5E,9aS)-5-(2-hydroxyethylidene)-7-methyl-4,5,6,7,8,9-hexahydro-1H-4,9a-ethano-7,13b-diazacyclonona[1,2,3-jk]fluorene-1,14-dione
C22H22N2O3 (362.16303419999997)
[(1S,2aR,8bR)-2-benzoyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-cyclopropylmethanone
C22H22N2O3 (362.16303419999997)
[(1R,2aS,8bS)-2-benzoyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-cyclopropylmethanone
C22H22N2O3 (362.16303419999997)
[(1R,2aR,8bR)-2-benzoyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-cyclopropylmethanone
C22H22N2O3 (362.16303419999997)
[(1S,2aS,8bS)-2-benzoyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-cyclopropylmethanone
C22H22N2O3 (362.16303419999997)
6-hydroxy-4,7-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydrocyclopenta[b]pyran-3-one
(4r,4ar,6s,7r,7as)-7-hydroxy-4,7-dimethyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydrocyclopenta[b]pyran-3-one
(5as,7as,11as,11br)-1-chloro-2-hydroxy-5a,8,8,11a-tetramethyl-7,7a,9,10,11,11b-hexahydro-6h-5-oxatetraphen-3-one
(1r,2r,4r)-2-hydroxy-4-(hydroxymethyl)-1-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethenyl)cyclohexane-1-carbaldehyde
(4r,4as,6s,7s,7ar)-7-hydroxy-4,7-dimethyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydrocyclopenta[c]pyran-3-one
1-o-β-d-glucopyranosylamplexin
{"Ingredient_id": "HBIN002855","Ingredient_name": "1-o-\u03b2-d-glucopyranosylamplexin","Alias": "NA","Ingredient_formula": "C16H26O9","Ingredient_Smile": "C=CC(COC1C(C(C(C(O1)CO)O)O)O)C2CCOC(=O)C2CO","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15611","TCMID_id": "8602","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(3r,3as,4r,5s,6as)-4-(hydroxymethyl)-5-methyl-3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-hexahydrocyclopenta[b]furan-2-one
4a-hydroxy-7-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydro-1h-cyclopenta[c]pyran-4-carbaldehyde
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2e,5r,6e)-5,8-dihydroxy-2,6-dimethylocta-2,6-dienoate
(2s)-5-hydroxy-n-[(2s)-1-[(2s)-2-(c-hydroxycarbonimidoyl)pyrrolidin-1-yl]-3-(3h-imidazol-4-yl)-1-oxopropan-2-yl]-3,4-dihydro-2h-pyrrole-2-carboximidic acid
(4s,4as,6s,7s,7ar)-7-hydroxy-4,7-dimethyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydrocyclopenta[c]pyran-3-one
(2s,3r,4s,5s,6r)-2-{[(1s,4ar,5r,7r,7ar)-4a,5-dihydroxy-4,7-dimethyl-1h,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
3-methylbutanoyl (2s,4z)-2-hydroxy-4-methyl-3-oxo-2-[(1s,2r,3r)-1,2,3,4-tetrahydroxybutyl]hex-4-enoate
methyl (15r,16s,20s)-15,16-dimethyl-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1,3,5,7,9,11,18-heptaene-19-carboxylate
C22H22N2O3 (362.16303419999997)
methyl 15,16-dimethyl-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1,3,5,7,9,11,18-heptaene-19-carboxylate
C22H22N2O3 (362.16303419999997)
(3s,4s)-3-(hydroxymethyl)-4-[(2r)-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-3-en-2-yl]oxan-2-one
3-(hydroxymethyl)-4-(1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-3-en-2-yl)oxan-2-one
3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 5,8-dihydroxy-2,6-dimethylocta-2,6-dienoate
(4s,4as,6s,7s,7ar)-6-hydroxy-4,7-dimethyl-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydrocyclopenta[c]pyran-3-one
(3s,4s)-3-(hydroxymethyl)-4-[(2s)-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-3-en-2-yl]oxan-2-one
(4r,4as,6s,7s,7ar)-7-(hydroxymethyl)-4-methyl-6-{[(2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydro-1h-cyclopenta[c]pyran-3-one
(4s,4ar,6s,7r,7as)-7-hydroxy-4,7-dimethyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydrocyclopenta[b]pyran-3-one
(2s,3r,4s,5s,6r)-2-{[(1s,4as,5r,7s,7as)-5,7-dihydroxy-4,7-dimethyl-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
3-{[3-({3-[(3-hydroxybutanoyl)oxy]butanoyl}oxy)butanoyl]oxy}butanoic acid
(1s,4r,4ar,7r,7ar)-4a-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydro-1h-cyclopenta[c]pyran-4-carbaldehyde
(1s,11r,12s,22r)-4-methyl-9-oxa-4,13-diazahexacyclo[9.8.3.2¹⁰,¹³.0¹,¹².0⁶,²².0¹⁴,¹⁹]tetracosa-6,10(24),14,16,18-pentaene-20,23-dione
C22H22N2O3 (362.16303419999997)